NASDAQ : RPRX
Royalty Pharma plc — Financial statements
Healthcare · Biotechnology · United States
Last price 67.18 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 38.63B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Royalty Pharma plc (RPRX) reported revenue of 2.54B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 2.54B | 2.38B | 2.26B | 2.35B | 2.24B | 2.29B |
| Cost of Revenue | 105.97M | -295.84M | 732.46M | 560.66M | 904.24M | 452.84M |
| Gross Profit | 2.43B | 2.67B | 1.53B | 1.79B | 1.33B | 1.84B |
| Selling, General & Admin | 633.08M | 573.48M | 236.67M | 249.75M | 227.30M | 182.83M |
| Research & Development | 238.64M | 452.00M | 2.00M | 52.00M | 177.11M | 200.08M |
| Amortization of Goodwill & Intangibles | 5.67M | 23.00M | ||||
| Operating Expenses | 877.59M | 1.11B | 238.67M | 301.75M | 410.08M | 405.91M |
| Operating Income | 1.55B | 1.56B | 1.29B | 1.49B | 922.89M | 1.43B |
| Interest Expense | -361.07M | -307.66M | -225.51M | -187.19M | -187.96M | -166.14M |
| Interest & Investment Income | 25.33M | 33.59M | 47.34M | 72.29M | 78.33M | 53.53M |
| Earnings From Equity Investments | 45.79M | 29.09M | 29.61M | 28.88M | -8.97M | -19.49M |
| Other Non Operating Income (Expenses) | -13.44M | -14.35M | -7.53M | -24.03M | 81.86M | -27.21M |
| EBT Excluding Unusual Items | 1.25B | 1.30B | 1.14B | 1.38B | 886.15M | 1.27B |
| Gain (Loss) on Sale of Investments | 138.57M | 24.01M | 194.46M | 317.98M | -40.26M | -30.21M |
| Asset Writedown | -69.44M | -615.83M | ||||
| Pretax Income | 1.35B | 1.32B | 1.33B | 1.70B | 230.06M | 1.24B |
| Earnings From Continuing Operations | 1.35B | 1.32B | 1.33B | 1.70B | 230.06M | 1.24B |
| Minority Interest in Earnings | -534.87M | -553.25M | -471.83M | -565.25M | -187.23M | -621.47M |
| Net Income | 811.99M | 770.95M | 858.98M | 1.13B | 42.83M | 619.73M |
| Net Income to Common | 811.99M | 770.95M | 858.98M | 1.13B | 42.83M | 619.73M |
| Shares Outstanding (Basic) | 435.54M | 429.80M | 448.19M | 447.60M | 437.96M | 414.79M |
| Shares Outstanding (Diluted) | 558.05M | 564.46M | 594.11M | 602.90M | 437.97M | 414.80M |
| EPS (Basic) | 1.86 | 1.79 | 1.92 | 2.54 | 0.10 | 1.49 |
| EPS (Diluted) | 1.86 | 1.78 | 1.91 | 2.53 | 0.10 | 1.49 |
| Dividend Per Share | 0.91 | 0.88 | 0.84 | 0.80 | 0.76 | 0.68 |
| Gross Margin | 95.82% | 112.44% | 67.64% | 76.19% | 59.58% | 80.22% |
| Operating Margin | 61.22% | 65.58% | 57.10% | 63.37% | 41.25% | 62.49% |
| Profit Margin | 32.02% | 32.42% | 37.95% | 48.20% | 1.92% | 27.07% |
| EBITDA | 1.56B | 1.56B | 1.50B | 928.56M | 1.45B | |
| EBITDA Margin | 61.41% | 65.74% | 63.61% | 41.50% | 63.50% | |
| D&A For EBITDA | 4.94M | 3.85M | 5.67M | 5.67M | 23.00M | |
| EBIT | 1.55B | 1.56B | 1.29B | 1.49B | 922.89M | 1.43B |
| EBIT Margin | 61.22% | 65.58% | 57.10% | 63.37% | 41.25% | 62.49% |
| Revenue as Reported | 2.54B | 2.38B | 2.26B | 2.35B | 2.24B | 2.29B |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 811.99M | 618.70M | 929.03M | 477.01M | 1.71B | 1.54B |
| Short-Term Investments | 25.00M | 18.80M | 58.20M | 18.30M | 25.72M | 647.87M |
| Cash & Short-Term Investments | 836.99M | 637.50M | 987.23M | 495.31M | 1.74B | 2.19B |
| Accounts Receivable | 920.93M | 883.70M | 810.73M | 760.84M | 727.92M | 682.66M |
| Receivables | 920.93M | 883.70M | 810.73M | 760.84M | 727.92M | 682.66M |
| Other Current Assets | 6.66M | 6.89M | 4.19M | 18.04M | 90.52M | 6.63M |
| Total Current Assets | 1.76B | 1.53B | 1.80B | 1.27B | 2.55B | 2.88B |
| Property, Plant & Equipment | 19.10M | |||||
| Long-Term Investments | 875.99M | 880.28M | 1.26B | 1.01B | 735.82M | 909.59M |
| Goodwill | 923.53M | 924.63M | ||||
| Other Intangible Assets | 5.32M | 1.78M | 14.50M | 5.67M | ||
| Long-Term Accounts Receivable | 16.19B | 16.21B | 15.13B | 14.09B | 13.49B | 13.72B |
| Other Long-Term Assets | 62.96M | 60.19M | 28.21M | 4.74M | 15.13M | 4.14M |
| Total Assets | 19.82B | 19.62B | 18.22B | 16.38B | 16.81B | 17.52B |
| Accounts Payable | 35.57M | 19.40M | 13.37M | 15.16M | 7.91M | 5.62M |
| Accrued Expenses | 107.77M | 110.82M | 98.06M | 51.68M | 54.16M | 57.70M |
| Current Portion of Long-Term Debt | 380.00M | 380.00M | 997.77M | 997.51M | ||
| Current Portion of Leases | 3.16M | |||||
| Other Current Liabilities | 107.60M | 122.83M | 144.41M | 94.53M | 107.20M | 107.93M |
| Total Current Liabilities | 630.93M | 636.21M | 1.25B | 161.38M | 1.17B | 171.25M |
| Long-Term Debt | 8.58B | 8.57B | 6.61B | 6.14B | 6.12B | 7.10B |
| Long-Term Leases | 16.10M | |||||
| Other Long-Term Liabilities | 821.24M | 682.61M | 12.08M | 900.00K | 2.50M | |
| Total Liabilities | 10.03B | 9.91B | 7.88B | 6.30B | 7.29B | 7.27B |
| Common Stock | 108.00K | 106.00K | 108.00K | 108.00K | 107.00K | 106.00K |
| Additional Paid-In Capital | 4.38B | 4.12B | 4.10B | 4.01B | 3.67B | 3.51B |
| Retained Earnings | 2.46B | 2.36B | 2.85B | 2.52B | 1.96B | 2.26B |
| Treasury Stock | -2.72M | -2.61M | -2.66M | -2.63M | -2.81M | -2.71M |
| Comprehensive Income & Other | 16.49M | |||||
| Total Common Equity | 6.83B | 6.48B | 6.95B | 6.53B | 5.63B | 5.78B |
| Minority Interest | 2.95B | 3.24B | 3.40B | 3.56B | 3.90B | 4.47B |
| Shareholders' Equity | 9.79B | 9.71B | 10.34B | 10.08B | 9.53B | 10.25B |
| Total Liabilities & Equity | 19.82B | 19.62B | 18.22B | 16.38B | 16.81B | 17.52B |
| Total Debt | 8.96B | 8.97B | 7.61B | 6.14B | 7.12B | 7.10B |
| Net Cash (Debt) | -8.12B | -8.33B | -6.63B | -5.64B | -5.38B | -4.91B |
| Net Cash Per Share | -14.56 | -14.76 | -11.15 | -9.35 | -12.28 | -11.83 |
| Filing Date Shares Outstanding | 445.28M | 428.42M | 433.32M | 446.69M | 443.17M | 432.96M |
| Total Common Shares Outstanding | 445.75M | 428.67M | 445.99M | 446.69M | 443.17M | 432.96M |
| Working Capital | 1.13B | 891.88M | 548.52M | 1.11B | 1.39B | 2.71B |
| Book Value Per Share | 15.33 | 15.11 | 15.58 | 14.61 | 12.70 | 13.34 |
| Tangible Book Value | 5.91B | 5.55B | 6.94B | 6.52B | 5.61B | 5.77B |
| Tangible Book Value Per Share | 13.26 | 12.95 | 15.56 | 14.61 | 12.67 | 13.33 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 811.99M | 770.95M | 858.98M | 1.13B | 42.83M | 619.73M |
| Depreciation & Amortization | 4.94M | 3.85M | 5.67M | 23.00M | ||
| Other Amortization | 30.79M | 28.64M | 19.56M | 20.50M | 21.36M | 20.16M |
| Asset Writedown & Restructuring Costs | 69.44M | 615.83M | ||||
| Loss (Gain) From Sale of Investments | -138.57M | -24.01M | -194.46M | -317.98M | 40.26M | 30.21M |
| Loss (Gain) on Equity Investments | -21.05M | -15.69M | -16.21M | -10.06M | 48.12M | 53.87M |
| Stock-Based Compensation | 427.67M | 289.89M | 2.34M | 2.36M | 2.17M | 2.44M |
| Provision & Write-off of Bad Debts | 105.97M | -295.84M | 732.46M | 560.66M | 904.24M | 452.84M |
| Other Operating Activities | -1.85B | -1.61B | -1.67B | -1.61B | -2.08B | -1.48B |
| Change in Accounts Receivable | 3.53B | 3.35B | 2.98B | 3.20B | 2.51B | 2.30B |
| Change in Accounts Payable | -14.57M | -13.93M | -2.29M | 6.24M | 2.29M | -4.59M |
| Change in Other Net Operating Assets | 18.48M | -3.22M | 55.67M | -854.00K | 30.38M | 8.39M |
| Operating Cash Flow | 2.98B | 2.49B | 2.77B | 2.99B | 2.14B | 2.02B |
| Cash Acquisitions | -226.00K | -74.42M | ||||
| Sale (Purchase) of Intangibles | -2.40B | -1.70B | -2.51B | -2.12B | -1.74B | -2.19B |
| Investment in Securities | -61.50M | 438.22M | -99.45M | 57.17M | 712.22M | 339.82M |
| Other Investing Activities | -53.03M | -280.26M | -72.96M | -14.44M | -18.60M | |
| Investing Cash Flow | -2.51B | -1.61B | -2.68B | -2.07B | -1.03B | -1.87B |
| Short-Term Debt Issued | 1.27B | 350.00M | ||||
| Long-Term Debt Issued | 1.95B | 1.47B | 1.27B | |||
| Total Debt Issued | 3.23B | 3.23B | 1.47B | 350.00M | 1.27B | |
| Short-Term Debt Repaid | -1.27B | -350.00M | ||||
| Long-Term Debt Repaid | -1.00B | -1.00B | ||||
| Total Debt Repaid | -2.27B | -2.27B | -1.35B | |||
| Net Debt Issued (Repaid) | 954.48M | 954.48M | 1.47B | -1.00B | 1.27B | |
| Repurchase of Common Stock | -321.77M | -1.23B | -229.65M | -304.76M | ||
| Common Dividends Paid | -399.06M | -378.25M | -376.46M | -358.33M | -333.32M | -285.18M |
| Other Financing Activities | -516.32M | -534.81M | -503.97M | -485.67M | -611.53M | -602.24M |
| Financing Cash Flow | -282.68M | -1.19B | 361.14M | -2.15B | -944.86M | 385.11M |
| Net Cash Flow | 180.08M | -310.33M | 452.02M | -1.23B | 169.70M | 532.37M |
| Levered Free Cash Flow | -1.20B | -670.41M | -1.76B | -1.24B | -1.38B | -1.55B |
| Unlevered Free Cash Flow | -993.07M | -500.56M | -1.64B | -1.15B | -1.29B | -1.46B |
| Cash Interest Paid | 315.55M | 276.29M | 159.57M | 169.17M | 170.14M | 130.43M |
| Change in Working Capital | 3.53B | 3.34B | 3.04B | 3.21B | 2.54B | 2.30B |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 38.25B | 16.51B | 11.33B | 12.50B | 17.43B | 17.12B |
| Enterprise Value | 46.37B | 27.73B | 21.33B | 21.13B | 27.33B | 26.69B |
| Last Close Price | 66.52 | 38.12 | 24.55 | 26.21 | 35.95 | 35.60 |
| PE Ratio | 35.68 | 21.41 | 13.20 | 11.01 | 407.00 | 27.62 |
| Forward PE | 12.07 | 7.70 | 6.09 | 7.47 | 10.32 | 13.00 |
| PS Ratio | 15.08 | 6.94 | 5.01 | 5.31 | 7.79 | 7.48 |
| PB Ratio | 4.34 | 1.70 | 1.10 | 1.24 | 1.83 | 1.67 |
| P/TBV Ratio | 6.47 | 2.97 | 1.63 | 1.92 | 3.10 | 2.97 |
| P/OCF Ratio | 12.85 | 6.63 | 4.09 | 4.18 | 8.13 | 8.48 |
| PEG Ratio | 1.62 | 0.79 | 2.14 | 2.65 | 0.94 | 1.12 |
| EV/Sales Ratio | 18.29 | 11.66 | 9.42 | 8.97 | 12.22 | 11.66 |
| EV/EBITDA Ratio | 29.78 | 17.73 | 14.11 | 29.44 | 18.36 | |
| EV/EBIT Ratio | 29.87 | 17.78 | 16.50 | 14.16 | 29.62 | 18.65 |
| Debt / Equity Ratio | 0.92 | 0.92 | 0.74 | 0.61 | 0.75 | 0.69 |
| Debt / EBITDA Ratio | 5.75 | 5.74 | 4.10 | 7.66 | 4.88 | |
| Net Debt / Equity Ratio | 0.83 | 0.86 | 0.64 | 0.56 | 0.56 | 0.48 |
| Net Debt / EBITDA Ratio | 5.22 | 5.33 | 3.77 | 5.79 | 3.38 | |
| Asset Turnover | 0.13 | 0.13 | 0.13 | 0.14 | 0.13 | 0.14 |
| Quick Ratio | 2.79 | 2.39 | 1.43 | 7.78 | 2.11 | 16.77 |
| Current Ratio | 2.80 | 2.40 | 1.44 | 7.90 | 2.19 | 16.81 |
| Return on Equity (ROE) | 13.96% | 13.20% | 13.03% | 17.34% | 2.33% | 12.32% |
| Return on Assets (ROA) | 5.09% | 5.15% | 4.67% | 5.62% | 3.36% | 5.33% |
| Return on Capital Employed (ROCE) | 8.10% | 8.20% | 7.60% | 9.20% | 5.90% | 8.20% |
| Earnings Yield | 2.80% | 4.67% | 7.58% | 9.08% | 0.25% | 3.62% |
| Dividend Yield | 1.41% | 2.28% | 3.31% | 2.86% | 1.93% | 1.72% |
| Payout Ratio | 50.42% | 49.06% | 43.83% | 31.57% | 778.21% | 46.02% |
| Buyback Yield / Dilution | 3.88% | 4.99% | 1.46% | -37.66% | -5.59% | -10.48% |
| Total Shareholder Return | 5.29% | 7.28% | 4.76% | -34.80% | -3.65% | -8.76% |